SGI-DNA

11099 North Torrey Pines Road
Suite 150
La Jolla
California
92037
United States

Tel: 1-855-474-4362

About SGI-DNA

SGI-DNA, a wholly-owned subsidiary of Synthetic Genomics, Inc. (SGI), is responsible for all commercial aspects of SGI’s synthetic DNA business and focuses on strategic business relationships with both academic and commercial researchers. Building on the scientific advancements and breakthroughs from leading scientists such as J. Craig Venter, Hamilton Smith, Clyde Hutchison, Dan Gibson and their teams, SGI-DNA utilizes unique and proprietary DNA technologies to produce complex synthetic genes and reagents. SGI-DNA also offers the BioXp™ 3200 System, the world’s first DNA printer, in addition to a comprehensive suite of genomic services, including whole genome sequencing, library design, bioinformatics services, and reagent kits to enable synthetic biology.
YEAR FOUNDED:
2013
LEADERSHIP:
Founders: J. Craig Venter, Hamilton Smith, and Dan Gibson
JOBS:
Please click here for SGI-DNA job opportunities.
PRODUCTS:
All Products
FOLLOW SGI-DNA:
Tweets by SGI-DNA

14 articles about SGI-DNA

SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)

2/18/2020

Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 outbreak, including co-funding purchases of BioXp™ 3200 System.
SGI-DNA Appoints Brian Donnelly as Chief Commercial Officer

12/23/2019

SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer
Gibson Assembly® Advances Field of DNA Digital Data Storage

10/1/2019

Gibson Assembly strategy successfully employed to significantly increase the throughput of DNA data storage and retrieval
SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch

9/9/2019

SGI-DNA, a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, has completed a $25 million Series A financing round led by Northpond Ventures, with participation from Oxford Finance and BroadOak Capital Partners
Life Sciences Industry Veteran Todd R. Nelson Named SGI-DNA CEO to Lead Spin-out from Synthetic Genomics

7/2/2018

SGI-DNA announced industry veteran Todd R. Nelson, Ph.D., MBA has been appointed Chief Executive Officer to lead the spin-out of the company from Synthetic Genomics, Inc. (SGI).
SGI-DNA And BioCat GmbH Announce Distribution Partnership For Vmax Express Protein Expression Platform

9/20/2017
SGI-DNA Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation

3/29/2017
SGI-DNA Launches Custom Cloning Module For BioXp 3200 System To Advance Protein And Antibody Engineering Capabilities

12/13/2016
SGI-DNA, A Synthetic Genomics, Inc. Company, Announces Exclusive Global Distribution Agreement For Reagents With VWR

7/20/2016
SGI-DNA Launches Automated Cloning Module For The BioXp 3200 System And Reaches Another Instrument Milestone

1/13/2016
SGI-DNA Launches Cell Engineering Services For Custom Cell Line Development

12/15/2015
SGI-DNA Launches Gibson Assembly Site-Directed Mutagenesis Kit For Accurate, Robust And Efficient Site-Directed Mutagenesis Of DNA Fragments

9/1/2015
SGI-DNA Receives Frost & Sullivan 2015 North American Synthetic Biology New Product Innovation Award For The BioXp 3200 System

8/4/2015
SGI-DNA Launches the BioXp 3200 System Early Access Program

4/2/2015